Whitehawk Therapeutics Inc beat EPS estimates 100% of the time across 3 reported quarters (3 beats, 0 misses), averaging +27.5% versus consensus. Data sourced from SEC EDGAR.
| Quarter | EPS Estimate | EPS Actual | Surprise | Result | Call |
|---|---|---|---|---|---|
| Q2 FY26 | $-0.30 | $-0.20 | +33.3% | Beat | |
| Q1 FY26 | $-0.36 | $-0.32 | +11.1% | Beat | |
| Q4 FY25 | $-0.55 | $-0.34 | +38.2% | Beat |
Back to WHWK overview · WHWK holders · WHWK KPIs
Data sourced from U.S. SEC EDGAR filings. Not personalized investment advice.